CLINICAL UTILIZATION OF HUMAN HEMATOPOIETIC PROGENITORS ELICITED IN PERIPHERAL-BLOOD BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHUG-CSF)

被引:2
作者
BREGNI, M
SIENA, S
BONADONNA, G
GIANNI, AM
机构
[1] Cristina Gandini Transplantation Unit, Division of Medical Oncology, Department of Cancer Medicine, 20133 Milano
关键词
D O I
10.1016/0959-8049(94)90098-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:235 / 238
页数:4
相关论文
共 21 条
[1]   EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON HEMATOPOIETIC RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].
BRANDT, SJ ;
PETERS, WP ;
ATWATER, SK ;
KURTZBERG, J ;
BOROWITZ, MJ ;
JONES, RB ;
SHPALL, EJ ;
BAST, RC ;
GILBERT, CJ ;
OETTE, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14) :869-876
[2]  
BREGNI M, 1992, BLOOD, V80, P1418
[3]  
BRUGGER W, 1992, BLOOD S, V80, pA519
[4]  
CHAO NJ, 1993, BLOOD, V81, P2031
[5]  
DUHRSEN U, 1988, BLOOD, V72, P2074
[6]   RAPID AND COMPLETE HEMATOPOIETIC RECONSTITUTION FOLLOWING COMBINED TRANSPLANTATION OF AUTOLOGOUS BLOOD AND BONE-MARROW CELLS - A CHANGING-ROLE FOR HIGH-DOSE CHEMO-RADIOTHERAPY [J].
GIANNI, AM ;
BREGNI, M ;
SIENA, S ;
VILLA, S ;
SCIORELLI, GA ;
RAVAGNANI, F ;
PELLEGRIS, G ;
BONADONNA, G .
HEMATOLOGICAL ONCOLOGY, 1989, 7 (02) :139-148
[7]   GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR OR GRANULOCYTE COLONY-STIMULATING FACTOR INFUSION MAKES HIGH-DOSE ETOPOSIDE A SAFE OUTPATIENT REGIMEN THAT IS EFFECTIVE IN LYMPHOMA AND MYELOMA PATIENTS [J].
GIANNI, AM ;
BREGNI, M ;
SIENA, S ;
MAGNI, M ;
DINICOLA, M ;
LOMBARDI, F ;
TARELLA, C ;
PILERI, A ;
BONADONNA, G .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) :1955-1962
[8]  
GIANNI AM, 1989, LANCET, V2, P580
[9]   PROLONGED DISEASE-FREE SURVIVAL AFTER HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY AND HEMATOPOIETIC AUTOLOGOUS TRANSPLANTATION IN POOR PROGNOSIS HODGKINS-DISEASE [J].
GIANNI, AM ;
SIENA, S ;
BREGNI, M ;
LOMBARDI, F ;
GANDOLA, L ;
VALAGUSSA, P ;
BONADONNA, G .
ANNALS OF ONCOLOGY, 1991, 2 (09) :645-653
[10]   RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR REDUCES HEMATOLOGIC TOXICITY AND WIDENS CLINICAL APPLICABILITY OF HIGH-DOSE CYCLOPHOSPHAMIDE TREATMENT IN BREAST-CANCER AND NON-HODGKINS-LYMPHOMA [J].
GIANNI, AM ;
BREGNI, M ;
SIENA, S ;
ORAZI, A ;
STERN, AC ;
GANDOLA, L ;
BONADONNA, G .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) :768-778